IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-40699-8.html
   My bibliography  Save this article

Antibody-mediated NK cell activation as a correlate of immunity against influenza infection

Author

Listed:
  • Carolyn M. Boudreau

    (MIT, and Harvard
    Harvard University)

  • John S. Burke

    (MIT, and Harvard)

  • Ashraf S. Yousif

    (MIT, and Harvard)

  • Maya Sangesland

    (MIT, and Harvard
    Harvard University)

  • Sandra Jastrzebski

    (UCONN Health Center)

  • Chris Verschoor

    (McMaster University)

  • George Kuchel

    (UCONN Health Center)

  • Daniel Lingwood

    (MIT, and Harvard)

  • Harry Kleanthous

    (SK Bioscience)

  • Iris Bruijn

    (Sanofi-Pasteur, Inc.)

  • Victoria Landolfi

    (Sanofi-Pasteur, Inc.)

  • Saranya Sridhar

    (Sanofi-Pasteur, Inc.)

  • Galit Alter

    (MIT, and Harvard)

Abstract

Antibodies play a critical role in protection against influenza; yet titers and viral neutralization represent incomplete correlates of immunity. Instead, the ability of antibodies to leverage the antiviral power of the innate immune system has been implicated in protection from and clearance of influenza infection. Here, post-hoc analysis of the humoral immune response to influenza is comprehensively profiled in a cohort of vaccinated older adults (65 + ) monitored for influenza infection during the 2012/2013 season in the United States (NCT: 01427309). While robust humoral immune responses arose against the vaccine and circulating strains, influenza-specific antibody effector profiles differed in individuals that later became infected with influenza, who are deficient in NK cell activating antibodies to both hemagglutinin and neuraminidase, compared to individuals who remained uninfected. Furthermore, NK cell activation was strongly associated with the NK cell senescence marker CD57, arguing for the need for selective induction of influenza-specific afucosylated NK activating antibodies in older adults to achieve protection. High dose vaccination, currently used for older adults, was insufficient to generate this NK cell-activating humoral response. Next generation vaccines able to selectively bolster NK cell activating antibodies may be required to achieve protection in the setting of progressively senescent NK cells.

Suggested Citation

  • Carolyn M. Boudreau & John S. Burke & Ashraf S. Yousif & Maya Sangesland & Sandra Jastrzebski & Chris Verschoor & George Kuchel & Daniel Lingwood & Harry Kleanthous & Iris Bruijn & Victoria Landolfi &, 2023. "Antibody-mediated NK cell activation as a correlate of immunity against influenza infection," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-40699-8
    DOI: 10.1038/s41467-023-40699-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-40699-8
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-40699-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Stylianos Bournazos & Davide Corti & Herbert W. Virgin & Jeffrey V. Ravetch, 2020. "Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection," Nature, Nature, vol. 588(7838), pages 485-490, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Felix Jünger & Dominic Ruh & Dominik Strobel & Rebecca Michiels & Dominik Huber & Annette Brandel & Josef Madl & Alina Gavrilov & Michael Mihlan & Caterina Cora Daller & Eva A. Rog-Zielinska & Winfrie, 2022. "100 Hz ROCS microscopy correlated with fluorescence reveals cellular dynamics on different spatiotemporal scales," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    2. Aaron Gupta & Kevin S. Kao & Rachel Yamin & Deena A. Oren & Yehuda Goldgur & Jonathan Du & Pete Lollar & Eric J. Sundberg & Jeffrey V. Ravetch, 2023. "Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody," Nature Communications, Nature, vol. 14(1), pages 1-11, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-40699-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.